化工社化工社 化学情報印刷レポート · 研究参考用
プロメタジン塩酸塩
N,N,α-トリメチル-10H-フェノチアジン-10-エタンアミン·塩酸塩 · 塩酸プロメタジン · ピレチア · ジプラシン · アトシル · フェネルガン · ジフェルガン塩酸塩 · 10-[2-(ジメチルアミノ)プロピル]-10H-フェノチアジン·塩酸塩
識別子と物理属性
| CAS No. | 58-33-3 |
|---|---|
| 分子式 | C17H20N2S.ClH |
| 平均分子量 | 320.9 g/mol |
| 単同位体質量 | 320.11139735 g/mol |
| SMILES | CC(CN1c2ccccc2Sc2ccccc21)N(C)C.Cl |
| InChIKey | XXPDBLUZJRXNNZ-UHFFFAOYSA-N |
| PubChem CID | 6014 |
| ChEMBL | CHEMBL1200750 |
| ChEBI | CHEBI:8462 |
| EC No. | 200-375-2 |
| DTXSID | DTXSID3021192 |
| 現地名 | プロメタジン塩酸塩 |
化学・物理的性質
| 極性表面積 | 31.8 |
|---|---|
| 水素結合供与体数 | 1 |
| 水素結合受容体数 | 3 |
| 回転可能結合数 | 3 |
| 重原子数 | 21 |
| 形式電荷 | 0 |
| 複雑度 | 298 |
| 溶解度 | greater than or equal to 100 mg/mL at 72 °F (NTP, 1992)水に非常に溶けやすく、エタノール (96%) および塩化メチレンに溶けやすい。 |
| Human Drugs | Breast FeedingLactationMilk, HumanAntiemeticsAntipruriticsPhenothiazinesFDA approved drugs -> Active ingredient |
| 融点 | 446 to 450 °F (decomposes) (NTP, 1992)230-232°C |
| Physical Description | Promethazine hydrochloride is an odorless white to faint yellow crystalline powder. Bitter taste. A 10% solution in water has a pH of 3.5-5.0. (NTP, 1992) |
| Collision Cross Section | 162.7 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards] |
| 引火点 | 9℃ |
| 貯蔵条件 | 2-8°C |
| 外観・状態 | Solid |
| 色 | White to Almost white |
| pH | pH (50g/L, 25℃) : 4.0～6.0 |
| 臭い | 無臭 |
| Merck | 14,7786 |
| BRN | 4166397 |
| BCS Class | 1,3 |
| 主な用途 | 医薬品（低分子化合物） |
| InChI | InChI=1S/C17H20N2S.ClH/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H31H |
| InChIKey | XXPDBLUZJRXNNZ-UHFFFAOYSA-N |
| SMILES | N1(CC(C)N(C)C)C2C=CC=CC=2SC2=CC=CC=C12.Cl |
| CAS データベース | 58-33-3(CAS DataBase Reference) |
| EPAの化学物質情報 | Promethazine hydrochloride (58-33-3) |
化学的特性
White Solid
安全性と法規制
| GHS 分類 | This chemical does not meet GHS hazard criteria for 0.7% (1 of 142) of reports.DangerH302 (92.3%): Harmful if swallowed [Warning Acute toxicity, oral]P261, P264, P264+P265, P270, P271, P272, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 142 reports by companies from 19 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| 規制情報 | 10H-Phenothiazine-10-ethanamine, N,N,.alpha.-trimethyl-, monohydrochloride: Does not have an individual approval but may be used under an appropriate group standard |
| その他の安全情報 | IMAP assessments - 10H-Phenothiazine-10-ethanamine, N,N,.alpha.-trimethyl-, monohydrochloride: Environment tier I assessment |
| 火災危険 | Flash point data for this chemical are not availablehowever, it is probably combustible. (NTP, 1992) |
| 健康有害性 | SYMPTOMS: Symptoms of exposure to this compound include excitement, sleepiness, convulsions and rigidity. Other symptoms include leukopenia, agranulocytosis, drowsiness, confusion and stupor. Acute transitory myopia may occur. Central nervous system effects may also occur. It may cause an increase in blood pressure, mild hypotension, jaundice, extra-pyramidal reactions and photosensitivity. It may also cause dizziness, central nervous system depression, vomiting, local anesthesia, abdominal pain, diarrhea and dryness of the mouth, throat and nose. Symptoms of exposure to this type of compound include muscular weakness, tachycardia, nausea, sedation, tinnitus, lassitude, incoordination, fatigue, blurred vision, diplopia, euphoria, nervousness, insomnia, tremors, loss of appetite, epigastric distress, constipation, cough, urinary retention or frequency, dysuria, palpitation, headache, tightness of the chest, tingling, heaviness and weakness of the hands, allergic dermatitis, fever, hemolytic anemia (rare), fixed and dilated pupils, and flushing. In children, exposure can cause hallucinations, excitement, ataxia, incoordination, athetosis and convulsions. |
| 反応性グループ | Amines, Phosphines, and Pyridines |
| Reactivity Profile | PROMETHAZINE HYDROCHLORIDE is sensitive to light. In aqueous solution, it is degraded by heat and light (more rapidly in air or oxygen). Incompatible with alkalis and alkaline solutions such as those of aminophylline, soluble barbiturates and phenytoin sodium. Iron(III) and copper(III) accelerate the degradation (NTP, 1992). |
| Air and Water Reactions | Slowly oxidizes in air, acquiring a blue color. Also turns blue on exposure to moisture. Water soluble. |
| Hazard Classes and Categories | Acute Tox. 4 (92.3%) |
| 消火 | Fires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992) |
| 応急処置 | EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. If symptoms (such as redness or irritation) develop, immediately transport the victim to a hospital. |
| 非火災時の漏出対応 | SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned. |
| Personal Protective Equipment (PPE) | RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. |
| 暴露経路 | On average, 88% of a promethazine dose is absorbed after oral administrationhowever, the absolute bioavailability is only 25% because of first-pass clearance. |
| 毒性の概要 | Like other H1-antagonists, promethazine competes with free histamine for binding at H1-receptor sites in the GI tract, uterus, large blood vessels, and bronchial muscle. The relief of nausea appears to be related to central anticholinergic actions and may implicate activity on the medullary chemoreceptor trigger zone. |
| Signs and Symptoms | Symptoms of overdose include mild depression of the central nervous system and cardiovascular system to profound hypotension, respiratory depression, unconsciousness, and sudden death. Other reported reactions include hyperreflexia, hypertonia, ataxia, athetosis, and extensor-plantar reflexes (Babinski reflex). |
| Carcinogen Classification | Promethazine HydrochlorideTR-425: Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CASRN 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies) (1993 )12/01/92No Evidence |
| Drug Induced Liver Injury | Drug Induced Liver Injury Rank (DILIrank 2.0)Promethazine hydrochloridevLess-DILI-concern5Adverse reactionsDOI:10.1016/j.drudis.2016.02.015 |
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
| Toxicity Data | IV, Mouse: LD<sub>50</sub>=55mg/kg |
| 水環境危害等級（WGK） | 3 |
| TSCA 収載状態 | TSCA listed |
| RTECS 番号 | SO8225000 |
| 輸送番号（UN） | UN 2811 6.1/PG 3 |
| 毒性 | LD50 i.v. in mice: 55.0 mg/kg (Rajsner) |
| 税関コード | 29343000 |
| 危険文句（R） | 22-36/37/38-51/53-43-20/22 |
| 危険表示 | Xn,N |
| 安全措置（S） | 26-36-61-60-36/37/39-28-22 |
| 危険等級 | 6.1(b)Acute Tox. 4 OralAquatic Chronic 2Eye Dam. 1Skin Sens. 1 |
| 包装等級 | III |
| 貯蔵分類 | 11 - Combustible Solids |
用途
用途
フェノチアジン誘導体です。 抗ヒスタミン作用を示します。
用途
神経化学研究用。
使用
Promethazine hydrochloride is used as antihistamine; antiemetic; central nervous system depressant; sedative; anticholinergic; antiserotoninergic; local anesthetic; in the treatment of motion sickness, cough linctuses, nausea, and allergic conditions; used to control Parkinsonian symptoms and as central nervous system depressant; in pills, syrup, injections and suppositories.
一般的な説明
Odorless white to faint yellow crystalline powder. Bitter taste. A 10% solution in water has a pH of 3.5-5.0.